Medicine and Dentistry
Systematic Review
100%
Surgery
87%
Diseases
79%
COVID-19
76%
Laparoscopic Cholecystectomy
75%
Meta-Analysis
67%
Diagnosis
59%
Infection
58%
Injury
54%
Cohort Analysis
53%
Intensive Care Unit
52%
Observational Study
52%
Bleeding
48%
Cholecystectomy
48%
Surgical Anastomosis
45%
Artificial Respiration
42%
Symptom
41%
Quality of Life
40%
Mortality Rate
39%
Esophagectomy
39%
Prevalence
36%
Neoplasm
35%
Odds Ratio
35%
Surgical Technique
34%
Malignant Neoplasm
33%
Health Care Cost
31%
Cross Sectional Study
31%
Geriatrics
31%
Abdominal Pain
30%
Anastomosis Leakage
30%
Overall Survival
28%
Pancreaticoduodenectomy
28%
Digestive System Surgery
27%
Surgical Mortality
26%
Oxygen Saturation
26%
Sepsis
25%
Bile
25%
Pancreatitis
25%
Hospital Mortality
24%
Apoplexy
24%
Interstitial Lung Disease
24%
Severe Acute Respiratory Syndrome Coronavirus 2
23%
Septic Shock
23%
Intensive Care
23%
Pneumothorax
22%
Activities of Daily Living
22%
Low and Middle Income Countries
22%
Health Care
22%
Prospective Cohort Study
21%
Cancer Surgery
21%
Emergency Department
21%
Randomized Controlled Trial
20%
Postoperative Complication
20%
Cholecystitis
20%
Elderly Patient
19%
Quality Improvement
19%
Bile Duct Injury
19%
Life Expectancy
19%
Logistic Regression Analysis
18%
Nocardia
18%
Centenarians
18%
Stomach Cancer
18%
Multiple Myeloma
18%
Pyeloplasty
18%
Common Hepatic Artery
18%
Total Hip Arthroplasty
18%
Empyema
18%
Tranexamic Acid
18%
Angiosarcoma
18%
Lymphoproliferative Disease
18%
Spontaneous Pneumothorax
18%
Synovial Sarcoma
18%
Stoma
18%
Dental Implant
18%
Oral Implants
18%
Retrospective Study
18%
Conservative Treatment
18%
Disease Free Survival
17%
Body Mass Index
17%
Surgeon
17%
Survival Time
16%
Recurrent Disease
16%
Hernia
16%
Acetylsalicylic Acid
16%
Necrosis
15%
Lymph Node
15%
Outpatient
15%
Pseudoaneurysm
15%
Cancer
15%
Chronic Pancreatitis
15%
Tomography
15%
Mesenteric Ischemia
15%
Endodontic Procedure
15%
Retrospective Cohort Study
15%
Hepatectomy
15%
Pancreas Fistula
14%
Lactate Dehydrogenase
14%
Acute Cholecystitis
14%
Parenteral Nutrition
14%
Disease Course
14%
Nursing and Health Professions
Systematic Review
45%
Hospital Mortality
31%
Laparoscopic Cholecystectomy
27%
Artificial Respiration
27%
Meta Analysis
21%
Quality of Life
21%
Cohort Analysis
20%
Adult Respiratory Distress Syndrome
18%
Network Meta-Analysis
18%
Intensive Care Unit
15%
Cross-Sectional Study
14%
Hospitalization
14%
Cognitive Defect
13%
Diseases
13%
Chronic Disease
13%
Confidence Interval
12%
Area under the Curve
11%
Infection
11%
Disease
10%
Cholecystitis
10%
Acute Cholecystitis
10%
Surgical Technique
10%
Hospital
9%
Prevalence
9%
Diagnostic Accuracy
9%
Embase
9%
Altitude
9%
Herniorrhaphy
9%
Surgical Risk
9%
Intermediate Care
9%
Nursing Staff
9%
Surgery
9%
Auditory Rehabilitation
9%
Hearing Impairment
9%
Alopecia Areata
9%
Lymphocyte Count
9%
Nutritional Assessment
9%
Minoxidil
9%
Bleeding
9%
Tracheostomy
9%
Hemoglobin Determination
9%
Health Service
9%
Tranexamic Acid
9%
Muscle Thickness
9%
Muscle Mass
9%
Procalcitonin
9%
Early Diagnosis
9%
Tracheal Intubation
9%
Cholecystectomy
9%
Body Mass
9%
Injury
9%
Hernioplasty
9%
Artificial Intelligence
9%
Pyeloplasty
9%
Checklist
9%
Cognitive Rehabilitation
9%
Evidence Based Nursing
9%
Total Hip Prosthesis
9%
Sedation
9%
Adolescent
9%
Clinical Examination
9%
Neck Injury
9%
Geriatric Care
9%
Tumor Necrosis
9%
Multiple Sclerosis
9%
Alka-Seltzer
9%
Anticonvulsive Agent
9%
Extubation
9%
Hip Fracture
9%
Early Goal-Directed Therapy
9%
New-Onset Atrial Fibrillation
9%
Normal Value
9%
Neutrophil Lymphocyte Ratio
9%
Intracranial Pressure
9%
Volunteer
9%
Clinical Outcome
9%
Malignant Neoplasm
9%
Neonatal Intensive Care Unit
9%
Patient Population
9%
Reverse Transcription Polymerase Chain Reaction
9%
Severe Acute Respiratory Syndrome
9%
Portal Vein Thrombosis
9%
Uric Acid
9%
Vasoactive Agent
9%
Parkinson's Disease
9%
Polyvinyl Alcohol
9%
Medline
8%
Functional Status
7%
Life Expectancy
7%
Placebo
7%
Receiver Operating Characteristic
7%
Necrosis
7%
Blood Pressure
6%
Nutrition Assessment
6%
Gestational Age
6%
Comorbidity
6%
Predictive Value
6%
Mortality Rate
6%
Sarcopenia
5%
Recurrent Disease
5%
Pharmacology, Toxicology and Pharmaceutical Science
Observational Study
28%
Coughing
19%
Base
18%
Coronavirinae
18%
Placebo
16%
Comorbidity
15%
Disease
13%
Mortality Rate
13%
Syndrome
12%
Life Expectancy
12%
Infection
11%
Cohort Study
10%
Adverse Event
10%
Chronic Disease
9%
Randomized Controlled Trial
9%
Prevalence
9%
Interstitial Lung Disease
9%
Cholecystitis
9%
Postoperative Complication
9%
Prospective Cohort Study
9%
SARS Coronavirus
9%
Adult Respiratory Distress Syndrome
9%
Tumor Necrosis Factor
9%
Minoxidil
9%
Alopecia Areata
9%
Methotrexate
9%
Cardiovascular Risk
9%
Genetic Risk
9%
Bronchitis
9%
Ivy
9%
Heart Arrest
9%
Tranexamic Acid
9%
Vaccination Policy
9%
Multiple Sclerosis
9%
Brain Abscess
9%
Nocardia
9%
Stomach Cancer
9%
Liver Metastasis
9%
Cardiomyopathy
9%
Stomach Paresis
9%
Morbidity
9%
Rhabdomyolysis
9%
Rosuvastatin
9%
Non Small Cell Lung Cancer
9%
Mild Cognitive Impairment
9%
Urinary Tract Infection
9%
Bile Duct Fistula
9%
Gallstone
9%
Mycobacterium Tuberculosis
9%
Common Bile Duct Stone
9%
Hypoxemia
9%
Ulcer Perforation
9%
Acute Appendicitis
9%
Bile Leakage
9%
Kidney Infarction
9%
Diuretic Agent
9%
Gamma Ray
9%
Restenosis
9%
Stenosis
9%
Neuroendocrine Tumor
9%
Chronic Diarrhea
9%
Bovine Leukemia Virus
9%
Chronic Obstructive Lung Disease
9%
Antibiotic Prophylaxis
9%
Cannabidiol
9%
Systemic Sclerosis
9%
Tumor Necrosis
9%
Nutrition Supplement
9%
Ileum
9%
Eosinophilic Gastroenteritis
9%
Contrast Induced Nephropathy
9%
Anticonvulsive Agent
9%
Ovary Polycystic Disease
9%
Ecological Study
9%
Hip Fracture
9%
New-Onset Atrial Fibrillation
9%
Tigecycline
9%
Abdominal Infection
9%
Primary Headache
9%
Tree
9%
Headache
9%
Multiple Myeloma
9%
Solitary Fibrous Tumor
9%
Ciclonicate
9%
Antiphospholipid Syndrome
9%
Autoantibodies
9%
Frailty
9%
Collagen Type 1
9%
Hospital Mortality
9%
Diseases
9%
Appendicitis
9%
Monoclonal Antibody
9%
Uric Acid
9%
Diffuse Lewy Body Disease
9%
Parkinson's Disease
9%
Triptan Derivative
9%
Glucagon Like Peptide 1 Receptor Agonist
9%
Glucagon-Like Peptide-1
9%
Acute Cholecystitis
7%
Lactate Dehydrogenase
6%